Seroprevalence and T-cell response in 32 children 10 months after COVID-19

Acta Paediatr. 2022 May;111(5):1042-1043. doi: 10.1111/apa.16287. Epub 2022 Feb 15.

Authors

David Moritz¹, Anders Krifors^{2

3

4}, Elisabeth Freyhult⁵, Emeli Månsson^{2

3

6}

Affiliations

¹ Department of Paediatrics, Uppsala University, Uppsala, Sweden.
² Department of Infectious Diseases, Västmanlands Hospital, Västerås, Sweden.
³ Centre of Clinical Research Region Västmanland, Uppsala University, Uppsala, Sweden.
⁴ Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Microbiology, Västmanlands Hospital, Västerås, Sweden.
⁶ School of Medical Sciences, Örebro University, Örebro, Sweden.

No abstract available

MeSH terms

Antibodies, Viral
COVID-19* / epidemiology
Child
Humans
SARS-CoV-2
Seroepidemiologic Studies
T-Lymphocytes

Substances

Antibodies, Viral

Grants and funding

Region Västmanland - Uppsala University, Centre for Clinical Research, Västmanlands hospital Västerås